研究業績

任意団体JBCRG論文・出版

2005年


Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancer.


Kuroi K,. Toi M, Tsuda H, Kurosumi M, Akiyama F; Japan Breast Cancer Research Group (JBCRG).


Biomed Pharmacother. 2005 Oct;59 Suppl 2:S387-92.

Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer


Ohno S, Toi M, Kuroi K, Nakamura S, Iwata H, Kusama M, Masuda N, Yamazaki K, Hisamatsu K, Sato Y, Takatsuka Y, Shin E, Kaise H, Kurozumi M, Tsuda H, Akiyama F; Japan Breast Cancer Research Group (JBCRG).


Biomed Pharmacother.2005 Oct;59 Suppl 2:S323-4.

Interim analysis of a phaseII trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breastcarcinoma


Iwata H, Nakamura S, Toi M, Shin E, Masuda N, Ohno S, Takatsuka Y,Hisamatsu K, Yamazaki K, Kusama M, Kaise H, Sato Y, Kuroi K, Akiyama F, Tsuda H, Kurosumi M; Japan Breast Cancer Research Group (JBCRG).


Breast Cancer. 2005;12(2):99-103.

一般社団法人JBCRGへ戻る